SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Psychotec
Psychotec Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Psychotec Spółka z Ograniczoną Odpowiedzialnością
Psychotec Spółka z Ograniczoną Odpowiedzialnością (KRS 0000065616, NIP 8130335789) is a Polish company, headquartered in Rzeszów, Podkarpackie voivodeship. PSYCHOTEC operates in: Other human health activities n.e.c. (PKD 86.90.E). Industry: Healthcare. The company has been listed in the National Court Register since November 26, 2001. PSYCHOTEC's most recently reported net revenue was 174.1 K PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
86.90.EOther human health activities n.e.c.
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Credibility rating
71.5 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
6
6/24 yrs
Board changes
5
5/24 yrs
PKD changes
4
4/24 yrs
Name changes
2
2/24 yrs
Data from 24 years of registry activity.
Payment reliability score from 2019–2023
Current: B (72/100)
Trend: improving (+5.1 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Standard limit from 2019–2023
Current: 25.9 K PLN
Safe: 16.8 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
November 26, 2001
24 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
RZESZÓW
PODKARPACKIE
Primary PKD
86.90.E
Other human health activities n.e.c.
Share capital
26.7 K PLN
16 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
5 years
2019–2023 · profitable: 4/5
Registry entries
60
latest: August 14, 2024
Revenue
174.1 K PLN
2023
Net profit
37.6 K PLN
2023
Assets
206.6 K PLN
2023
Equity
133.5 K PLN
2023
Valuation
284.7 K PLN
High confidence
Rate business credibility - Psychotec.
No ratings

News
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.

Explainer
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
PSYCHOTEC's board has 1 member.
20 historical registry entries for Psychotec
Filing documents submitted (6 documents)
Filing documents submitted (2 documents)
Filing document
Company name change, Board change, Shareholder change, Articles of association amended, Primary PKD code change, Secondary PKD code change
RZ.XII NS-REJ.KRS/19653/23/71
Filing document
Latest reporting year
2023
Available years
23
Filing entries
0
Competing companies or those operating in the same market segment as Psychotec (in Rzeszów, industry: Healthcare).
RZESZÓW· Healthcare
Revenue 2022: 33.2 M PLN
JAROSŁAW· Healthcare
Revenue 2018: 21.0 M PLN
TARNOBRZEG· Healthcare
Revenue 2024: 6.5 M PLN
ŁĘŻYNY· Healthcare
Revenue 2024: 3.5 M PLN
SANOK· Healthcare
Revenue 2024: 3.4 M PLN
RZESZÓW· Healthcare
Revenue 2025: 1.3 M PLN